Logo image of CABKA.AS

CABKA (CABKA.AS) Stock Fundamental Analysis

AMS:CABKA - Euronext Amsterdam - NL00150000S7 - Common Stock - Currency: EUR

2  -0.03 (-1.48%)

Fundamental Rating

2

CABKA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 12 industry peers in the Containers & Packaging industry. CABKA has a bad profitability rating. Also its financial health evaluation is rather negative. CABKA is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CABKA has reported negative net income.
In the past year CABKA had a positive cash flow from operations.
CABKA had negative earnings in 4 of the past 5 years.
In the past 5 years CABKA always reported a positive cash flow from operatings.
CABKA.AS Yearly Net Income VS EBIT VS OCF VS FCFCABKA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

CABKA's Return On Assets of -5.39% is on the low side compared to the rest of the industry. CABKA is outperformed by 78.57% of its industry peers.
Looking at the Return On Equity, with a value of -16.49%, CABKA is doing worse than 85.71% of the companies in the same industry.
With a Return On Invested Capital value of 0.11%, CABKA is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -5.39%
ROE -16.49%
ROIC 0.11%
ROA(3y)-7.32%
ROA(5y)-4.89%
ROE(3y)-19.85%
ROE(5y)-13.7%
ROIC(3y)N/A
ROIC(5y)N/A
CABKA.AS Yearly ROA, ROE, ROICCABKA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30 -40

1.3 Margins

CABKA has a Operating Margin of 0.07%. This is in the lower half of the industry: CABKA underperforms 78.57% of its industry peers.
In the last couple of years the Operating Margin of CABKA has declined.
CABKA has a better Gross Margin (49.83%) than 71.43% of its industry peers.
CABKA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 0.07%
PM (TTM) N/A
GM 49.83%
OM growth 3Y-68.98%
OM growth 5Y-54.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y-0.57%
CABKA.AS Yearly Profit, Operating, Gross MarginsCABKA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CABKA is destroying value.
The number of shares outstanding for CABKA remains at a similar level compared to 1 year ago.
CABKA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CABKA is higher compared to a year ago.
CABKA.AS Yearly Shares OutstandingCABKA.AS Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CABKA.AS Yearly Total Debt VS Total AssetsCABKA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.29, we must say that CABKA is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.29, CABKA is doing worse than 85.71% of the companies in the same industry.
CABKA has a Debt/Equity ratio of 0.69. This is a neutral value indicating CABKA is somewhat dependend on debt financing.
CABKA has a Debt to Equity ratio of 0.69. This is comparable to the rest of the industry: CABKA outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACC0.01
WACC7.29%
CABKA.AS Yearly LT Debt VS Equity VS FCFCABKA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

CABKA has a Current Ratio of 0.90. This is a bad value and indicates that CABKA is not financially healthy enough and could expect problems in meeting its short term obligations.
CABKA has a worse Current ratio (0.90) than 71.43% of its industry peers.
A Quick Ratio of 0.43 indicates that CABKA may have some problems paying its short term obligations.
CABKA has a worse Quick ratio (0.43) than 78.57% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.43
CABKA.AS Yearly Current Assets VS Current LiabilitesCABKA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

CABKA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -505.76%.
CABKA shows a decrease in Revenue. In the last year, the revenue decreased by -7.63%.
Measured over the past years, CABKA shows a small growth in Revenue. The Revenue has been growing by 2.52% on average per year.
EPS 1Y (TTM)-505.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-187.06%
Revenue 1Y (TTM)-7.63%
Revenue growth 3Y2.28%
Revenue growth 5Y2.52%
Sales Q2Q%-3.26%

3.2 Future

Based on estimates for the next years, CABKA will show a very strong growth in Earnings Per Share. The EPS will grow by 55.85% on average per year.
CABKA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.06% yearly.
EPS Next Y138.1%
EPS Next 2Y97.6%
EPS Next 3Y93.15%
EPS Next 5Y55.85%
Revenue Next Year3.41%
Revenue Next 2Y5.42%
Revenue Next 3Y6.72%
Revenue Next 5Y4.06%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CABKA.AS Yearly Revenue VS EstimatesCABKA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M
CABKA.AS Yearly EPS VS EstimatesCABKA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 0.2 0.3 0.4 0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

CABKA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 97.09 indicates a quite expensive valuation of CABKA.
CABKA's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CABKA is more expensive than 71.43% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, CABKA is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 97.09
CABKA.AS Price Earnings VS Forward Price EarningsCABKA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

64.29% of the companies in the same industry are more expensive than CABKA, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.61
CABKA.AS Per share dataCABKA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

CABKA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CABKA's earnings are expected to grow with 93.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y97.6%
EPS Next 3Y93.15%

More info and screens

5

5. Dividend

5.1 Amount

CABKA has a Yearly Dividend Yield of 7.75%, which is a nice return.
CABKA's Dividend Yield is rather good when compared to the industry average which is at 3.27. CABKA pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, CABKA pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.75%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of CABKA are negative and hence is the payout ratio. CABKA will probably not be able to sustain this dividend level.
DP-39.63%
EPS Next 2Y97.6%
EPS Next 3Y93.15%
CABKA.AS Yearly Income VS Free CF VS DividendCABKA.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M

More info and screens

CABKA

AMS:CABKA (7/4/2025, 7:00:00 PM)

2

-0.03 (-1.48%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners53.45%
Ins Owner ChangeN/A
Market Cap81.40M
Analysts85.45
Price Target4.15 (107.5%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 7.75%
Yearly Dividend0.15
Dividend Growth(5Y)N/A
DP-39.63%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-11.59%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-77.14%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 97.09
P/S 0.45
P/FCF N/A
P/OCF 4.95
P/B 1.43
P/tB 1.51
EV/EBITDA 7.61
EPS(TTM)-0.38
EYN/A
EPS(NY)0.02
Fwd EY1.03%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.4
OCFY20.2%
SpS4.47
BVpS1.39
TBVpS1.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.39%
ROE -16.49%
ROCE 0.14%
ROIC 0.11%
ROICexc 0.11%
ROICexgc 0.11%
OM 0.07%
PM (TTM) N/A
GM 49.83%
FCFM N/A
ROA(3y)-7.32%
ROA(5y)-4.89%
ROE(3y)-19.85%
ROE(5y)-13.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-70.71%
ROICexcg growth 5Y-54.98%
ROICexc growth 3Y-70.91%
ROICexc growth 5Y-54.99%
OM growth 3Y-68.98%
OM growth 5Y-54.16%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.2%
GM growth 5Y-0.57%
F-Score4
Asset Turnover1.05
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF N/A
Debt/EBITDA 1.92
Cap/Depr 92.89%
Cap/Sales 10.3%
Interest Coverage 0.03
Cash Conversion 80.98%
Profit Quality N/A
Current Ratio 0.9
Quick Ratio 0.43
Altman-Z 1.29
F-Score4
WACC7.29%
ROIC/WACC0.01
Cap/Depr(3y)138.03%
Cap/Depr(5y)116.14%
Cap/Sales(3y)12.71%
Cap/Sales(5y)11.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-505.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-187.06%
EPS Next Y138.1%
EPS Next 2Y97.6%
EPS Next 3Y93.15%
EPS Next 5Y55.85%
Revenue 1Y (TTM)-7.63%
Revenue growth 3Y2.28%
Revenue growth 5Y2.52%
Sales Q2Q%-3.26%
Revenue Next Year3.41%
Revenue Next 2Y5.42%
Revenue Next 3Y6.72%
Revenue Next 5Y4.06%
EBIT growth 1Y-95.24%
EBIT growth 3Y-68.28%
EBIT growth 5Y-53%
EBIT Next Year740.29%
EBIT Next 3Y131.17%
EBIT Next 5Y66.79%
FCF growth 1Y48.38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-39.52%
OCF growth 3Y-9.12%
OCF growth 5Y-4.78%